Clinical Researcher—February 2019 (Volume 33, Issue 2) SPECIAL FEATURE Ann Neuer, MBA The subject of adverse events (AEs) is often summed up as a series of definitions […]
Clinical Researcher—February 2019 (Volume 33, Issue 2) SPECIAL FEATURE Robert Barton The U.S. Food and Drug Administration’s (FDA’s) proposed rule to allow an institutional review board (IRB) […]
Clinical Researcher—February 2019 (Volume 33, Issue 2) DATA-TECH CONNECT Esther Daemen, MBA; Tine Wouters, MSc The General Data Protection Regulation (GDPR) (2016/679) brought about the greatest change […]
Clinical Researcher—February 2019 (Volume 33, Issue 2) EXECUTIVE DIRECTOR’S MESSAGE Jim Kremidas Clinical research is a valuable profession, and it deserves to be treated as such. Whether […]
Clinical Researcher—February 2019 (Volume 33, Issue 2) CHAIR’S MESSAGE John P. Neal, CRCP We’ve had a strong start out of the gate for 2019, and the year ahead […]